Summary:
- Medpace Holdings' Q1 2025 revenue increased by 9.3%, exceeding Wall Street forecasts.
- Earnings per share outperformed expectations by 20.8%, yet the stock fell by 6.4% post-announcement.
- Analysts forecast a potential 23.5% upside with a "Hold" recommendation for Medpace Holdings.
Medpace Holdings' Strong Q1 2025 Performance
Medpace Holdings (MEDP, Financial) recently unveiled its impressive first-quarter results for 2025. The company's revenue surged by 9.3% year-over-year, hitting $558.6 million. This figure not only surpassed Wall Street forecasts by 6% but also highlighted Medpace's robust operational capabilities. Furthermore, earnings per share (EPS) were reported at $3.67, exceeding analyst predictions by a remarkable 20.8%. Despite these stellar results, the stock experienced a 6.4% decline following the announcement, a move that has puzzled many investors.
Wall Street Analysts Price Target and Recommendations
Analysts on Wall Street have set their one-year price targets for Medpace Holdings Inc (MEDP, Financial), offering insights into the potential direction of the stock. The average target price is $330.33, with estimates ranging from a high of $404.00 to a low of $280.00. This suggests a potential upside of 23.50% from its current trading price of $267.47. For more detailed estimate data, visit the Medpace Holdings Inc (MEDP) Forecast page.
Currently, the consensus from 11 brokerage firms places Medpace Holdings Inc (MEDP, Financial) at an average recommendation of 2.6. This is indicative of a "Hold" rating on a scale where 1 represents a Strong Buy and 5 indicates Sell.
GuruFocus Insights: GF Value
According to GuruFocus estimates, the GF Value for Medpace Holdings Inc (MEDP, Financial) over the next year is projected at $365.69, suggesting a significant upside of 36.72% from its present price of $267.47. The GF Value is an estimate of the fair value at which the stock should be traded, calculated using the stock's historical trading multiples, past business growth, and future performance estimates. For more comprehensive data, consult the Medpace Holdings Inc (MEDP) Summary page.
